Characterization of proinsulin-insulin intermediates in human plasma
about
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.Biochemical and clinical implications of proinsulin conversion intermediates.Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.Pancreatic and extrapancreatic galanin release during sympathetic neural activation.Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.Evidence of a paracrine role for pancreatic somatostatin in vivo.Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin.Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs.Insulin glargine: the first clinically useful extended-acting insulin in half a century?Importance of validation of immunoassays for intact proinsulin.
P2860
Q34197036-520CEA8C-4B07-43A8-BF9B-4BEC9095432DQ34525950-26FA7984-31CE-4084-B118-D4543487ED97Q34558557-25C85A32-6270-4F14-94EB-CBFFE6BC365AQ34600465-B4102529-A3B3-4898-9919-56F0C43750F5Q41136480-681805CC-C3B2-4B75-B420-8E3A7DA58B52Q41344408-B0A0E052-02A6-4D31-9AD8-49D5879C68BFQ41535276-1484D565-2B02-4D0F-BCC1-6AB44C096B49Q41913648-36726453-6074-4C9C-909D-EA5B1F7DE94BQ46821363-E81F005F-3357-4F50-AE90-C780DF9A9B64Q51514519-B3F67D3B-4592-4A99-99BB-0E6C90B225D1Q51547505-5B833AD2-4596-49E8-8B90-BE53F2827062
P2860
Characterization of proinsulin-insulin intermediates in human plasma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of proinsulin-insulin intermediates in human plasma
@en
Characterization of proinsulin-insulin intermediates in human plasma.
@nl
type
label
Characterization of proinsulin-insulin intermediates in human plasma
@en
Characterization of proinsulin-insulin intermediates in human plasma.
@nl
prefLabel
Characterization of proinsulin-insulin intermediates in human plasma
@en
Characterization of proinsulin-insulin intermediates in human plasma.
@nl
P2093
P2860
P356
P1476
Characterization of proinsulin-insulin intermediates in human plasma
@en
P2093
P2860
P304
P356
10.1172/JCI109183
P407
P577
1978-10-01T00:00:00Z